TFF Pharmaceuticals’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

TFF Pharmaceuticals is a biopharmaceutical company that develops novel therapeutics for the treatment of chronic respiratory diseases. Read more

Glenn Mattes's photo - President & CEO of TFF Pharmaceuticals

President & CEO

Glenn Mattes

CEO Approval Rating

88/100

Founded:

2018

Status:

PublicNASDAQTFFP

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Theravance has been one of TFF Pharmaceuticals's top competitors. Theravance was founded in 1996, and is headquartered in South San Francisco, California. Theravance competes in the Pharmaceuticals industry. Theravance generates $63.6M more revenue vs. TFF Pharmaceuticals.

Pulmatrix is a top competitor of TFF Pharmaceuticals. Pulmatrix is a Public company that was founded in Lexington, Massachusetts in 2013. Like TFF Pharmaceuticals, Pulmatrix also competes in the Pharmaceuticals industry. Pulmatrix has 18 more employees vs. TFF Pharmaceuticals.

Altavant Sciences is perceived as one of TFF Pharmaceuticals's biggest rivals. Altavant Sciences was founded in 2018, and its headquarters is in Cary, North Carolina. Like TFF Pharmaceuticals, Altavant Sciences also operates in the Pharmaceuticals field. Altavant Sciences has 21 more employees than TFF Pharmaceuticals.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Pharmatek Laboratories a competitor of TFF Pharmaceuticals?

Quarterly and Annual Revenue

Coming soon for TFF Pharmaceuticals!

Annual Revenue

Acquisitions

No recent acquisitions found related to TFF Pharmaceuticals

TFF Pharmaceuticals Funding History

$14M$44.2M$70.1M

Since TFF Pharmaceuticals was founded in 2018, it has participated in 4 rounds of funding. In total TFF Pharmaceuticals has raised $70.1M. TFF Pharmaceuticals' last funding round was on Aug 2020 for a total of $25.9M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Private Placement
Aug 2020
$25.9M
-
IPO
Oct 2019
$22M

Series A
May 2019
$8.2M
-
Series A
Apr 2018
$14M

Total Funding: $70.1M

Since TFF Pharmaceuticals was founded in 2018, it has participated in 4 rounds of funding. In total TFF Pharmaceuticals has raised $70.1M. TFF Pharmaceuticals' last funding round was on Aug 2020 for a total of $25.9M

Investments

No recent investments found related to TFF Pharmaceuticals

TFF Pharmaceuticals News

August 26, 2020MarketScreener

Corporate Presentation

(marketscreener.com) Advanced Technology for Better Drug Delivery Options M a y 2 0 2 0 C o r p o r a... See more »
August 26, 2020Outsourcing-Pharma

TFF, Union Therapeutics join on potential COVID-19 treatment

The companies will partner on developing dry-powder forms of niclosamide as a treatment for the virus... See more »
August 24, 2020FiercePharma

Union, TFF team up to fight COVID-19 with inhaled tapeworm med

Union, TFF team up to fight COVID-19 with inhaled tapeworm med fkansteiner Mon, 08/24/2020 - 12:01... See more »
August 17, 2020Contract Pharma

TFF Pharmaceuticals Signs Worldwide Licensing Agreement with Union Therapeutics

Will develop dry powder forms of niclosamide as a potential COVID-19 treatment.... See more »
August 17, 2020The Business Journals: Austin

TFF Pharmaceuticals could receive $210M for part in coronavirus treatment development

A promising treatment for the novel coronavirus could get a big boost from Austin scientists. TFF sta... See more »

TFF Pharmaceuticals Press Releases

May 14, 2020Business Wire

TFF Pharmaceuticals Reports First Quarter 2020 Financial and Business Results

AUSTIN, Texas--(BUSINESS WIRE)--TFF Pharmaceuticals reports first quarter 2020 financial and business... See more »
April 30, 2020centralcharts

TFF Pharmaceuticals' Inventor Dr. Robert O. Williams III Presents Session on Repurposing Niclosamide for COVID-19 Treatment at AAPS Meeting

TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on devel... See more »

Headquarters

2600 Via Fortuna Suite 360

Austin, Texas78746

215-880-2632

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

TFF Pharmaceuticals is a biopharmaceutical company that develops novel therapeutics for the treatment of chronic respiratory diseases. TFF Pharmaceuticals was founded in 2018. TFF Pharmaceuticals' headquarters is located in Austin, Texas, USA 78746. I...

CEO

TFF Pharmaceuticals's President & CEO, Glenn Mattes, currently has an approval rating of 88%. TFF Pharmaceuticals's primary competitors are Theravance, Pulmatrix & Altavant Sciences.

Website

tffpharma.com

Frequently Asked Questions about TFF Pharmaceuticals

  1. When was TFF Pharmaceuticals founded?

    TFF Pharmaceuticals was founded in 2018
  2. Who is TFF Pharmaceuticals's CEO?

    TFF Pharmaceuticals's CEO is Glenn Mattes
  3. How much revenue does TFF Pharmaceuticals generate?

    TFF Pharmaceuticals generates $ < 1M in revenue
  4. How much funding does TFF Pharmaceuticals have?

    TFF Pharmaceuticals has historically raised $70.1M in funding
  1. Where is TFF Pharmaceuticals's headquarters?

    TFF Pharmaceuticals's headquarters is in Austin Texas, USA
  2. How many employees does TFF Pharmaceuticals have?

    TFF Pharmaceuticals has 4 employees
  3. What sector does TFF Pharmaceuticals operate in?

    TFF Pharmaceuticals is in Pharmaceuticals
  4. Who are TFF Pharmaceuticals's competitors?

    TFF Pharmaceuticals's top competitors are Theravance, Pulmatrix, Altavant Sciences